Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Crane NXT Announces Dates for Third Quarter 2026 Earnings Release and Earnings Call
-
Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
-
Base Carbon Announces Fifth Issuance of Carbon Credits from Rwanda Cookstoves Project
-
ChatGPT Takes the Lead Over Claude in Clash of AIs Competition
-
Form 8.3 - Eleco Plc
-
EverCommerce Announces Date of Third Quarter 2026 Earnings Call
-
IMPAUER TECHNOLOGIES ANNOUNCES COMMERCIAL LAUNCH OF PAUERONE WALLET V1 ACROSS ANDROID, WEB, AND BROWSER EXTENSION
-
SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies
-
YYForce Launches Yolara AI Workforce Intelligence Platform in Singapore
-
Form 8.5 (EPT/RI)-SThree plc
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026
-
Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME)
-
R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026
-
Copper Road Signs Exploration Agreement with the Matachewan First Nation on the Ben Nevis Volcanic Complex Project
-
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
-
Southern Saskatchewan farmers getting ready to round up pesticides and livestock medications for Fall collection events
-
Xali Gold Appoints Susan Mitchell as Senior Financial Advisor
-
Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome
-
Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026
-
Aurora Mobile's GPTBots.ai Helps NTS Turn 38 Years of Contact Center Expertise into Human-Led AI
-
Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Works
-
Aurora Mobile's GPTBots.ai Helps NTS Turn 38 Years of Contact Center Expertise into Human-Led AI
-
Rethink Partners with Joe Fresh™ & Shoppers Foundation for Women's Health™
-
Origin Launches Stress-Tolerant Corn Breeding for Southwest China Markets, with Supports from Guizhou State Entities
-
Lotus and WasabiCard Explored Enterprise‑Driven Stablecoin Payment Use‑Cases during TOKEN2049 Singapore
-
Plug Power Reports Continued Business Progress, Sets Dates for Third Quarter 2026 Earnings Call and Global Plug Symposium
-
Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
-
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
-
Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027
-
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
-
Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab
-
Certiverse Launches Self-Starter Subscriptions, Cutting the Cost of Certification by 80% as AI Reshapes the Skills Employers Need to Verify
-
PyroGenesis Completes Seven-System Drosrite™ Deployment at World’s Largest Aluminum Complex
-
First Advantage to Release Third Quarter 2026 Financial Results and Hold Investor Conference Call on November 5, 2026
-
Brunswick Exploration Announces 302 Metre-Wide Spodumene-Bearing Pegmatite Interval at the Anatacau Main Project
-
PlaneSense to equip entire fleet of PC-12 turboprops and PC-24 Jets with Gogo Galileo connectivity
-
illumin Holdings Inc. announces date for third quarter 2026 financial and operating results
-
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
-
OMass Therapeutics Announces $310 Million Series C Financing to Advance Portfolio of Small Molecule Therapeutics in Endocrinology and Immunology
-
Ohalo becomes DataXray, adopting the name its customers already use
-
Salvia BioElectronics Initiates Pivotal Study with First Patient in the U.S. Receiving Ultra Thin Neuromodulation Implant for Resistant Migraine
-
REGO Payment Architectures Launches REGO Guardian Global Child-Safety SaaS Licensing Infrastructure, Starting with the $121 Billion Mobile Gaming Industry
-
Form 8.5 (EPT/RI)-Tribal Group Plc
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Wallbox and EDP électrique deploy EV charging infrastructure at Montréal Metropolitan Airport
-
DT Midstream to Announce Third Quarter 2026 Financial Results, Schedules Earnings Call
-
Aegon completes exchange of all Common Shares B for common stock
-
LEPAS L6 EV to Embark on LEPAS Global Elegance Drive: Real Roads, Real Driving Dynamics
-
Northland’s Hai Long Offshore Wind Project Reaches Major Milestone: All 73 Turbines Installed and Generating Power
